Loading…
Cardioprotective Effect of Rheum turkestanicum Against Doxorubicin-Induced Toxicity in Rats
Background: Doxorubicin as an anti-cancer drug causes cardiotoxicity, limiting its tolerability and use. The mechanism of toxicity is due to free radical production and cardiomyocytes injury. This research evaluated Rheum turkestanicum ( R.turkestanicum ) extract against doxorubicin cardiotoxicity d...
Saved in:
Published in: | Frontiers in pharmacology 2022-06, Vol.13 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c372t-d75735957cc6a9dffed6b55b3e1cf0bc932f0ef98653d5cac10f8acb70fbe6663 |
---|---|
cites | cdi_FETCH-LOGICAL-c372t-d75735957cc6a9dffed6b55b3e1cf0bc932f0ef98653d5cac10f8acb70fbe6663 |
container_end_page | |
container_issue | |
container_start_page | |
container_title | Frontiers in pharmacology |
container_volume | 13 |
creator | Hosseini, Azar Safari, Mohammad-Kazem Rajabian, Arezoo Boroumand-Noughabi, Samaneh Eid, Ali H. Al Dhaheri, Yusra Gumpricht, Eric Sahebkar, Amirhossein |
description | Background:
Doxorubicin as an anti-cancer drug causes cardiotoxicity, limiting its tolerability and use. The mechanism of toxicity is due to free radical production and cardiomyocytes injury. This research evaluated
Rheum turkestanicum
(
R.turkestanicum
) extract against doxorubicin cardiotoxicity due to its considerable
in vitro
antioxidant activity.
Methods:
Male Wistar rats received 2.5 mg/kg doxorubicin intraperitoneally every other day for 2 weeks to create an accumulative dose.
R. turkestanicum
was administrated at a dose of 100 and 300 mg/kg intraperitoneally from the second week for 7 days. On the 15th day, the animals were anesthetized and blood was collected from cardiac tissue for evaluation of alanine aminotransferase (ALT), cardiac muscle creatinine kinase (CK-MB), troponin T (cTn-T), lactate dehydrogenase (LDH), and B-type natriuretic peptide brain natriuretic peptide. A cardiac homogenate was also collected to determine superoxide dismutase (SOD), catalase Catalase Activity, malondialdehyde (MDA), and thiols. Histopathology was also performed.
Results:
Doxorubicin increased all cardiac enzymes and malondialdehyde, correlating with a reduction in SOD, catalase, and thiols. Histopathology revealed extracellular edema, moderate congestion, and hemorrhage of foci. In contrast, administration of
R. turkestanicum
ameliorated these doxorubicin-induced pathophysiological changes.
Conclusion:
This study revealed that the extract ameliorated doxorubicin-induced cardiac toxicity via modulation of oxidative stress-related pathways. Liquid chromatography-mass spectrometry analysis of
R. turkestanicum
indicated several components with potent pharmacological properties. |
doi_str_mv | 10.3389/fphar.2022.909079 |
format | article |
fullrecord | <record><control><sourceid>pubmedcentral_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a1f46e860c994b1e8520beaea3468c4f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_a1f46e860c994b1e8520beaea3468c4f</doaj_id><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_9213811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-d75735957cc6a9dffed6b55b3e1cf0bc932f0ef98653d5cac10f8acb70fbe6663</originalsourceid><addsrcrecordid>eNpVkcFOHDEMhqOKqiDKA3CbF5glmUwyk0sltKWwElIlRE8cIsdxdkN3J6tMBsHbM7CoKr7Yvy1_lvUzdi74QsreXIT9BvKi4U2zMNzwznxhJ0JrWZteNEf_1cfsbBwf-RzSGKnbb-xYqk61bWdO2MMSso9pn1MhLPGJqqsQ5qpKobrb0LSrypT_0lhgiDiryzXEYSzVz_Sc8uQixqFeDX5C8tV9ep51eaniUN1BGb-zrwG2I5195FP259fV_fKmvv19vVpe3tYou6bUvlOdVEZ1iBqMn8977ZRykgQG7tDIJnAKptdKeoWAgoce0HU8ONLzl6dsdeD6BI92n-MO8otNEO17I-W1hVwibsmCCK2mXnM0pnWCetVwR0AgW91jG2bWjwNrP7kdeaShZNh-gn6eDHFj1-nJmkbIXogZIA4AzGkcM4V_u4LbN-Psu3H2zTh7ME6-AkZRjus</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cardioprotective Effect of Rheum turkestanicum Against Doxorubicin-Induced Toxicity in Rats</title><source>PubMed Central</source><creator>Hosseini, Azar ; Safari, Mohammad-Kazem ; Rajabian, Arezoo ; Boroumand-Noughabi, Samaneh ; Eid, Ali H. ; Al Dhaheri, Yusra ; Gumpricht, Eric ; Sahebkar, Amirhossein</creator><creatorcontrib>Hosseini, Azar ; Safari, Mohammad-Kazem ; Rajabian, Arezoo ; Boroumand-Noughabi, Samaneh ; Eid, Ali H. ; Al Dhaheri, Yusra ; Gumpricht, Eric ; Sahebkar, Amirhossein</creatorcontrib><description>Background:
Doxorubicin as an anti-cancer drug causes cardiotoxicity, limiting its tolerability and use. The mechanism of toxicity is due to free radical production and cardiomyocytes injury. This research evaluated
Rheum turkestanicum
(
R.turkestanicum
) extract against doxorubicin cardiotoxicity due to its considerable
in vitro
antioxidant activity.
Methods:
Male Wistar rats received 2.5 mg/kg doxorubicin intraperitoneally every other day for 2 weeks to create an accumulative dose.
R. turkestanicum
was administrated at a dose of 100 and 300 mg/kg intraperitoneally from the second week for 7 days. On the 15th day, the animals were anesthetized and blood was collected from cardiac tissue for evaluation of alanine aminotransferase (ALT), cardiac muscle creatinine kinase (CK-MB), troponin T (cTn-T), lactate dehydrogenase (LDH), and B-type natriuretic peptide brain natriuretic peptide. A cardiac homogenate was also collected to determine superoxide dismutase (SOD), catalase Catalase Activity, malondialdehyde (MDA), and thiols. Histopathology was also performed.
Results:
Doxorubicin increased all cardiac enzymes and malondialdehyde, correlating with a reduction in SOD, catalase, and thiols. Histopathology revealed extracellular edema, moderate congestion, and hemorrhage of foci. In contrast, administration of
R. turkestanicum
ameliorated these doxorubicin-induced pathophysiological changes.
Conclusion:
This study revealed that the extract ameliorated doxorubicin-induced cardiac toxicity via modulation of oxidative stress-related pathways. Liquid chromatography-mass spectrometry analysis of
R. turkestanicum
indicated several components with potent pharmacological properties.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2022.909079</identifier><identifier>PMID: 35754479</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>cardiotoxicity ; chemotherapy ; doxorubicin ; herbal medicine ; oxidative stress ; Pharmacology ; Rheum turkestanicum</subject><ispartof>Frontiers in pharmacology, 2022-06, Vol.13</ispartof><rights>Copyright © 2022 Hosseini, Safari, Rajabian, Boroumand-Noughabi, Eid, Al Dhaheri, Gumpricht and Sahebkar. 2022 Hosseini, Safari, Rajabian, Boroumand-Noughabi, Eid, Al Dhaheri, Gumpricht and Sahebkar</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-d75735957cc6a9dffed6b55b3e1cf0bc932f0ef98653d5cac10f8acb70fbe6663</citedby><cites>FETCH-LOGICAL-c372t-d75735957cc6a9dffed6b55b3e1cf0bc932f0ef98653d5cac10f8acb70fbe6663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213811/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213811/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Hosseini, Azar</creatorcontrib><creatorcontrib>Safari, Mohammad-Kazem</creatorcontrib><creatorcontrib>Rajabian, Arezoo</creatorcontrib><creatorcontrib>Boroumand-Noughabi, Samaneh</creatorcontrib><creatorcontrib>Eid, Ali H.</creatorcontrib><creatorcontrib>Al Dhaheri, Yusra</creatorcontrib><creatorcontrib>Gumpricht, Eric</creatorcontrib><creatorcontrib>Sahebkar, Amirhossein</creatorcontrib><title>Cardioprotective Effect of Rheum turkestanicum Against Doxorubicin-Induced Toxicity in Rats</title><title>Frontiers in pharmacology</title><description>Background:
Doxorubicin as an anti-cancer drug causes cardiotoxicity, limiting its tolerability and use. The mechanism of toxicity is due to free radical production and cardiomyocytes injury. This research evaluated
Rheum turkestanicum
(
R.turkestanicum
) extract against doxorubicin cardiotoxicity due to its considerable
in vitro
antioxidant activity.
Methods:
Male Wistar rats received 2.5 mg/kg doxorubicin intraperitoneally every other day for 2 weeks to create an accumulative dose.
R. turkestanicum
was administrated at a dose of 100 and 300 mg/kg intraperitoneally from the second week for 7 days. On the 15th day, the animals were anesthetized and blood was collected from cardiac tissue for evaluation of alanine aminotransferase (ALT), cardiac muscle creatinine kinase (CK-MB), troponin T (cTn-T), lactate dehydrogenase (LDH), and B-type natriuretic peptide brain natriuretic peptide. A cardiac homogenate was also collected to determine superoxide dismutase (SOD), catalase Catalase Activity, malondialdehyde (MDA), and thiols. Histopathology was also performed.
Results:
Doxorubicin increased all cardiac enzymes and malondialdehyde, correlating with a reduction in SOD, catalase, and thiols. Histopathology revealed extracellular edema, moderate congestion, and hemorrhage of foci. In contrast, administration of
R. turkestanicum
ameliorated these doxorubicin-induced pathophysiological changes.
Conclusion:
This study revealed that the extract ameliorated doxorubicin-induced cardiac toxicity via modulation of oxidative stress-related pathways. Liquid chromatography-mass spectrometry analysis of
R. turkestanicum
indicated several components with potent pharmacological properties.</description><subject>cardiotoxicity</subject><subject>chemotherapy</subject><subject>doxorubicin</subject><subject>herbal medicine</subject><subject>oxidative stress</subject><subject>Pharmacology</subject><subject>Rheum turkestanicum</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkcFOHDEMhqOKqiDKA3CbF5glmUwyk0sltKWwElIlRE8cIsdxdkN3J6tMBsHbM7CoKr7Yvy1_lvUzdi74QsreXIT9BvKi4U2zMNzwznxhJ0JrWZteNEf_1cfsbBwf-RzSGKnbb-xYqk61bWdO2MMSso9pn1MhLPGJqqsQ5qpKobrb0LSrypT_0lhgiDiryzXEYSzVz_Sc8uQixqFeDX5C8tV9ep51eaniUN1BGb-zrwG2I5195FP259fV_fKmvv19vVpe3tYou6bUvlOdVEZ1iBqMn8977ZRykgQG7tDIJnAKptdKeoWAgoce0HU8ONLzl6dsdeD6BI92n-MO8otNEO17I-W1hVwibsmCCK2mXnM0pnWCetVwR0AgW91jG2bWjwNrP7kdeaShZNh-gn6eDHFj1-nJmkbIXogZIA4AzGkcM4V_u4LbN-Psu3H2zTh7ME6-AkZRjus</recordid><startdate>20220608</startdate><enddate>20220608</enddate><creator>Hosseini, Azar</creator><creator>Safari, Mohammad-Kazem</creator><creator>Rajabian, Arezoo</creator><creator>Boroumand-Noughabi, Samaneh</creator><creator>Eid, Ali H.</creator><creator>Al Dhaheri, Yusra</creator><creator>Gumpricht, Eric</creator><creator>Sahebkar, Amirhossein</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220608</creationdate><title>Cardioprotective Effect of Rheum turkestanicum Against Doxorubicin-Induced Toxicity in Rats</title><author>Hosseini, Azar ; Safari, Mohammad-Kazem ; Rajabian, Arezoo ; Boroumand-Noughabi, Samaneh ; Eid, Ali H. ; Al Dhaheri, Yusra ; Gumpricht, Eric ; Sahebkar, Amirhossein</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-d75735957cc6a9dffed6b55b3e1cf0bc932f0ef98653d5cac10f8acb70fbe6663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>cardiotoxicity</topic><topic>chemotherapy</topic><topic>doxorubicin</topic><topic>herbal medicine</topic><topic>oxidative stress</topic><topic>Pharmacology</topic><topic>Rheum turkestanicum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hosseini, Azar</creatorcontrib><creatorcontrib>Safari, Mohammad-Kazem</creatorcontrib><creatorcontrib>Rajabian, Arezoo</creatorcontrib><creatorcontrib>Boroumand-Noughabi, Samaneh</creatorcontrib><creatorcontrib>Eid, Ali H.</creatorcontrib><creatorcontrib>Al Dhaheri, Yusra</creatorcontrib><creatorcontrib>Gumpricht, Eric</creatorcontrib><creatorcontrib>Sahebkar, Amirhossein</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hosseini, Azar</au><au>Safari, Mohammad-Kazem</au><au>Rajabian, Arezoo</au><au>Boroumand-Noughabi, Samaneh</au><au>Eid, Ali H.</au><au>Al Dhaheri, Yusra</au><au>Gumpricht, Eric</au><au>Sahebkar, Amirhossein</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardioprotective Effect of Rheum turkestanicum Against Doxorubicin-Induced Toxicity in Rats</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2022-06-08</date><risdate>2022</risdate><volume>13</volume><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>Background:
Doxorubicin as an anti-cancer drug causes cardiotoxicity, limiting its tolerability and use. The mechanism of toxicity is due to free radical production and cardiomyocytes injury. This research evaluated
Rheum turkestanicum
(
R.turkestanicum
) extract against doxorubicin cardiotoxicity due to its considerable
in vitro
antioxidant activity.
Methods:
Male Wistar rats received 2.5 mg/kg doxorubicin intraperitoneally every other day for 2 weeks to create an accumulative dose.
R. turkestanicum
was administrated at a dose of 100 and 300 mg/kg intraperitoneally from the second week for 7 days. On the 15th day, the animals were anesthetized and blood was collected from cardiac tissue for evaluation of alanine aminotransferase (ALT), cardiac muscle creatinine kinase (CK-MB), troponin T (cTn-T), lactate dehydrogenase (LDH), and B-type natriuretic peptide brain natriuretic peptide. A cardiac homogenate was also collected to determine superoxide dismutase (SOD), catalase Catalase Activity, malondialdehyde (MDA), and thiols. Histopathology was also performed.
Results:
Doxorubicin increased all cardiac enzymes and malondialdehyde, correlating with a reduction in SOD, catalase, and thiols. Histopathology revealed extracellular edema, moderate congestion, and hemorrhage of foci. In contrast, administration of
R. turkestanicum
ameliorated these doxorubicin-induced pathophysiological changes.
Conclusion:
This study revealed that the extract ameliorated doxorubicin-induced cardiac toxicity via modulation of oxidative stress-related pathways. Liquid chromatography-mass spectrometry analysis of
R. turkestanicum
indicated several components with potent pharmacological properties.</abstract><pub>Frontiers Media S.A</pub><pmid>35754479</pmid><doi>10.3389/fphar.2022.909079</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1663-9812 |
ispartof | Frontiers in pharmacology, 2022-06, Vol.13 |
issn | 1663-9812 1663-9812 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_a1f46e860c994b1e8520beaea3468c4f |
source | PubMed Central |
subjects | cardiotoxicity chemotherapy doxorubicin herbal medicine oxidative stress Pharmacology Rheum turkestanicum |
title | Cardioprotective Effect of Rheum turkestanicum Against Doxorubicin-Induced Toxicity in Rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T00%3A21%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardioprotective%20Effect%20of%20Rheum%20turkestanicum%20Against%20Doxorubicin-Induced%20Toxicity%20in%20Rats&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Hosseini,%20Azar&rft.date=2022-06-08&rft.volume=13&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2022.909079&rft_dat=%3Cpubmedcentral_doaj_%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_9213811%3C/pubmedcentral_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-d75735957cc6a9dffed6b55b3e1cf0bc932f0ef98653d5cac10f8acb70fbe6663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/35754479&rfr_iscdi=true |